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Abstract
Primary hyperparathyroidism (PHPT) is characterized with primary hyperproduction of parathyroid hormone 
(PTH) by affected parathyroid glands and with a corresponding increase in concentration of extracellular calcium. 
Long-term development of PHPT through decades leads to calcium-related symptoms and distinct changes in the skel-
eton, kidneys, digestive tract and other organs. In the clinical picture of PHPT, granulomatous pseudo-tumors in bones 
are observed as a rare manifestation of the disease – these lesions, which could imitate malignancy, are called «brown 
tumors». The present publication that goes into details about a clinical diagnosis, in which a brown tumor became the 
primary manifestation of PHPT, may be useful for physicians across various fields.
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1. Introduction
Primary hyperparathyroidism (PHPT) is characterized by primary hyperproduction of 
parathyroid hormone (PTH) and by a corresponding elevation of extracellular calcium level. PTH 
acts to increase the concentration of calcium in extracellular fluid by triggering the release of calci-
um and phosphates from the bone matrix, renal calcium reabsorption and mediated by Vitamin D3 
enhanced digestive absorption of calcium. Long-term development of PHPT through decades leads 
to distinct (and sometimes irreversible) changes in the skeleton, kidneys, biliary tract and other 
organs. In developed countries, the predominant way of PHPT discovering is the screening of ele-
vated blood calcium level; thus, new cases of PHPT are largely reported as mild or asymptomatic 
forms. Establishing the diagnosis of PHPT is essentially a laboratory task, and actually it requires 
only two parameters to match: the elevated levels of serum calcium and serum PTH. The clinical 
diagnosis of PHPT is complicated by the lack of specific symptoms; such symptoms as suscepti-
bility to fractures, thirst, bone pain, urinary and biliary stones indicate a late stage of the disease. 
In the clinical picture of PHPT granulomatous pseudo-tumors in bones are observed as a rare 
manifestation of the disease. These lesions, which are called «brown tumors», are a consequence 
of excessive bone resorption and remodeling, which are directly mediated by PHT. Brown tumors 
are more common in patients with secondary hyperparathyroidism related to renal failure, in which 
the level of PTH sometimes reaches 1000–3000 pg/mL; but they may appear in severe cases of 
PHPT as well [1]. Radiological signs of brown tumors are characterized by deformation of long 
bones (femur, tibia, shoulder) or spongy bones (ribs, collarbone, hip bones), accompanied by bone 
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erosion or tumor-like bone formations [2]. In practice, many cases of bone “brown” tumorssimu-
late malignancy, and doctors rarely suspect PHPT initially [3]. Even the elevated level of serum 
calcium accompanied by a bone tumor is more likely to be perceived by a clinician as a paraneo-
plastic or metastatic hypercalcemia, rather than brown tumor appearance of severe long standing 
PHPT [4]. To differentiate metastatic bone lesions from parathyroid carcinoma and brown tu-
mor arising in presence of parathyroid adenoma positronemission to mography with fluoro-2- 
deoxy-D-glucose (FDG) was proposed; authors found intensive FDG uptake in brown tumor but 
not in parathyroid adenoma [5]. There are very few published examples that offer an illustrated and 
well documented case of brown bone tumor in a patient with PHPT, so we consider this study to 
bea useful and interesting medical information for doctors of different profiles (endocrinologists, 
oncologists, surgeons, trauma orthopedists, radiologists).
2. Case Report
Woman, 28, became ill in August 2015. Clinical symptoms consisted of general weak-
ness, nausea, lack of appetite, thirst (about 5 liters of liquid consumed per day), frequent urination 
(4–5 times per night). A family doctorsupposed the diagnosis of chronic gastritis exacerbation, and 
the relevant treatment lasted two months. No positive dynamic was observed; conversely, an ad-
ditional symptoms of pain in the bones of spine and lower limbs appeared. Pain killers brought no 
relief. Because of the leg and back pain, the patient started to limp on her left leg. A source of pain 
and a swelling were revealed in the upper third of the left tibia. Topical treatment was introduced; 
after the radiography, a radiologist suspected a myeloma. The patient was sent for consultation to 
a hematologist-oncologist, who in turn directed her to National Cancer Institute, Kyiv, Ukraine. 
In the Institute, she was examined by a hematologist-oncologist and an orthopedic oncologist. On 
December 24, 2015 X-ray examination of the skeleton was performed. The X-ray of the tibia is 
shown on Fig. 1.
Fig. 1. Radiography of Lower Limb Bones: Brown Tumor in Left Tibia
The hematologist-oncologist assigned needle biopsy of bone marrow, and the conclusion 
was obtained on January 11, 2016: no bone marrow lesions were observed. Core biopsy of tumor in 
the tibia was additionally performed, which on January 19, 2016 yielded the following result: the 
biopsied material contain fibroplastic tissue with angiomatosis, microhemorrhages, and multinu-
cleated giant cells of osteoclastictype, that are arranged in clusters and laid separately. Given the 
clinical data (multifocal lesions), a brown tumor related to hyperparathyroidism was suspected. It 
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was eventually recommended to determine the level of parathyroid hormone and ionized calcium 
(the uniqueness of the situation is that a pathologist has been the first to diagnose PHPT!). The 
patient turned for consultation to Ukrainian Scientific and Practical Center for Endocrine Surgery, 
Endocrine Organs and Tissue Transplantation. The patient presented the results of examinations 
performed in National Cancer Institute, as well as the results of laboratory analyses from Janu-
ary 28, 2016: PTH – 1064 pg/mL (the normal level is 15–65 pg/mL); calcium total – 3.28 mmol/L 
(norm.: 2.2–2.55 mmol/L); calcium ionized – 1.94 mmol/L (norm.: 1.05–1.30 mmol/L); phospho-
rus – 0.54 mmol/L (norm.: 0.81–1.45 mmol/L); vitamin D (25-OH) – 5.1 ng/mL (norm.: 30–100 ng/mL). 
In the clinical conditions, the patient went through the standard examination. Ultrasonography 
(US) of the neck was performed February 09, 2016, which revealed a hypoechoic structure, sized 
25×24 mm attached to the lower pole of the left thyroid lobe. Thyroid gland is normal. The US ex-
aminations of internal organs and urinary system have not identified any abnormalities. The thyroid 
function was not compromised and the level of thyroid stimulating hormone (TSH) was 1.23 mIU/L 
(norm.: 0.5–3.5 mIU/L). Dual-energy X-ray absorbtiometry (DXA) revealed osteopenic syndrome 
(Total body bone density: BMD – 0.968 g/cm3, T-score: – 2.0, Z-score: – 2.6). The patient was pre-
scribed 3000 IU of Ergocalciferol per day and scheduled for surgery. After the short-term prepara-
tion in the surgical ward, the operation was performed on February 19, 2016: bilateral neck revision 
from Kocher incision; removal of adenoma of the left lower parathyroid gland; selective central 
neck dissection; lymphadenectomy. Intraoperative frozen section biopsy confirmed the removal of 
parathyroid adenoma (Fig. 2), 35×25 mm large and 6350 mg in weight; lymph nodes of the central 
neck compartmentdidn’t contain metastases.
Fig. 2. Adenoma of the Parathyroid Gland
An hour after the surgery the PTH level dropped to 36.7 pg/mL (norm.: 15–65 pg/mL); the 
decrease in ionized calcium was not so significant – 1.86 mmol/L (norm.: 1.05–1.30 mmol/L). Clin-
ical signs of hypocalcemia were recorded only 3 days after the surgery, and a significant decreasing 
of ionized calcium was observed at 6th dayafter the surgery (1.20 mmol/L), while the patient was 
receiving 2 µg of Alfacalcidol and 2000 mg of calcium per day. The patient also continued to take 
Ergocalciferolduring recommended 2 months course. The patient was discharged in a satisfactory 
condition; follow-up checks were scheduled to control the levels of PTH, calcium, phosphorus, 
and vitamin D at 3, 6 and 12 months. Also, the schedule included a control DXA examination in 
12 months, and radiography of the lower limb bones in 6 and 12 months.
3. Pathological Examenation
Inour Department of Pathology was examined histological material obtained by the core 
biopsy of brown tumor of the tibia and parathyroidectomy.
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Pathological examination of the biopsied tibia tumor fragment revealed numerous giant 
cells surrounded by fusiform stromal cells. In the stroma, extensive areas of hemorrhage were 
defined [6, 7]. Histopathological diagnosis: brown tumor related to hyperparathyroidism (Fig. 3).
Fig. 3. Brown Tumor Related To Hyperparathyroidism. Numerous giant cells surrounded by 
fusiform stromal cells. Hematoxylin and eosin stain, ×400
Histopathological examination of parathyroid tumor revealed its mostly solid structure, with 
defined zone of trabecular structure. The tumor was built from parathyroid chief cells with central-
ly located hyperchromic, monomorphic nuclei and faintly eosinophilic cytoplasm. The tumor was 
surrounded by a thin capsule of connective tissue. A normal parathyroid gland tissue was located 
around the tumor. Histopathological diagnosis: adenoma of parathyroid gland (Fig. 4).
Fig. 4. Adenoma of Parathyroid gland.Hematoxylin and eosin stain; ×200
4. Discussion
Primary hyperparathyroidism is one of the most common diseases of the endocrine system, 
with 3–5 occurrences per 1,000 in the population (and up to 3 % among women aged over 60). On 
the other hand, distinct clinical features are being found in PHPT patients to a smaller extent, and 
true diagnosis is often delayed when serum calcium is not screened. Only by increasing the overall 
awareness among physicians of such a widespread disease as PHPT we might prevent unneces-
sary and dangerous treatments, such as resection or biopsy of bones that contain pseudo-tumors. 
A laboratory analysis, in which high blood calcium level coincide with high level of PTH, is a 
compelling argument for low probability of a malignant bone lesion with accompanying hypercal-
cemia: in that case, the PTH level is always reduced. Differential diagnosis of brown tumor related 
to hyperparathyroidism includes giant cell tumor, reparative granuloma, and bone aneurysms [8]. 
Some authors connect probability of severe bone involvement during the course of PHPT with vi-
tamin D deficiency [9]. Presented clinical case might be crucially related with prominent vitamin D 
deficiency. Biochemically proven PHPT diagnosis andradiological signs of brown tumor generally 
abandon theneed in core biopsy of altered bone. A full regression of brown tumors is observed 
within 1–3 years after recovery from PHPT [10].
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5. Conclusions
Universal screening of hypercalcemiais essential for timely diagnosis of PHPT. Educational 
program that could raise awareness among physicians about bone manifestations of hyperparathy-
roidism, such as brown tumors, allows reducing diagnostic and treatment errors.
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